ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Verstockt, Bram
Alsoud, Dahham
Outtier, An
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su462
引用
收藏
页码：S702 / S702
页数：1
相关论文
共 50 条
  • [41] Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
    Gabrielli, Anna Maria Carvalhas
    Ferretti, Francesca
    Monico, Camilla Maria
    Tombetti, Enrico
    Maconi, Giovanni
    Romeo, Samanta
    Sed, Nicole Piazza O.
    Caprioli, Flavio
    Mazzola, Anna Maria
    Alicante, Saverio
    Berte, Roberto
    Lolli, Elisabetta
    Scribano, Maria Lia
    Buscarini, Elisabetta
    Ricci, Chiara
    Carmagnola, Stefania
    Ardizzone, Sandro
    Cannatelli, Rosanna
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1785 - 1792
  • [42] Tofacitinib induction therapy in ulcerative colitis can be prolonged
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (12): : 1742 - +
  • [43] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [44] Failed Tofacitinib Rescue Therapy in Acute Severe Ulcerative Colitis Refractory to Steroids and Anti-TNF Therapy
    Patel, Sanket
    Vaziri, Haleh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1795 - S1795
  • [45] Outcomes at one year after sequential use of high-dose tofacitinib following infliximab in Acute Severe Ulcerative Colitis
    Eqbal, A.
    Hilley, P.
    Gilmore, R.
    Suen, C. Li Wai
    Choy, M.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 548 - 548
  • [46] A MUCOSAL MARKER PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS
    Verstockt, Bram
    Verstockt, Sare
    Alsoud, Dahham
    Sabino, Joao
    Ferrante, Marc
    Vermeire, Severine
    GASTROENTEROLOGY, 2020, 158 (06) : S688 - S689
  • [47] A mucosal marker predicting tofacitinib induced an endoscopic response in ulcerative colitis
    Verstockt, B.
    Verstockt, S.
    Alsaoud, D.
    Sabino, J.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S358 - S359
  • [48] Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study
    State, Monica
    Balanescu, Paul
    Voiosu, Theodor
    Bengus, Andreea
    Voiosu, Andrei
    Coman, Andrei
    Mustatea, Petronel
    Negreanu, Lucian
    Mateescu, Radu Bogdan
    Popp, Cristiana
    BIOMEDICINES, 2023, 11 (07)
  • [49] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Lee, Scott D.
    Allegretti, Jessica R.
    Steinwurz, Flavio
    Connelly, Susan B.
    Lawendy, Nervin
    Paulissen, Jerome
    Gecse, Krisztina B.
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [50] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Scott D. Lee
    Jessica R. Allegretti
    Flavio Steinwurz
    Susan B. Connelly
    Nervin Lawendy
    Jerome Paulissen
    Krisztina B. Gecse
    BMC Gastroenterology, 23
12345